East Lansing and Ann Arbor, MI – October 2, 2019 – GreenMark Biomedical Inc. today announced it has been awarded a $1.5m Phase II Small Business Innovation Research (SBIR) grant to further develop its patented nanoparticle-based dental technology for detection of early stage dental caries. The 2-year project involves collaboration with dental and biomaterials experts at […]
Read MoreAnn Arbor, MI – October 3, 2018 – GreenMark Biomedical Inc. today announced it secured funding for its patented dental technology that identifies ‘pre-cavities’ which can be treated non-invasively before becoming cavities. This will have major implications for treatment of tooth decay prior to the need for surgical treatment, resulting in improved oral health outcomes for […]
Read MoreAnn Arbor, MI – June 29, 2018 – GreenMark Biomedical Inc. today announced that it closed on $500K in equity investment. The round is led by BlueWater Angel Investment Network (BWA) of Saginaw, MI and funds flowed in May and June as part of a Rolling Close. Biosciences Research & Commercialization Center (BRCC), an early stage […]
Read MoreLansing, MI – June 10, 2016 – GreenMark Biomedical Inc. today announced an agreement relating to the transfer of certain intellectual property from EcoSynthetix Inc. (TSX: ECO), a renewable chemicals company that produces a portfolio of biobased products. GreenMark, a Delaware start-up corporation with facilities in Michigan, was formed for the purpose of delivering health benefits […]
Read More